Department of Dental Medicine and Oral Health, Division of Oral Surgery and Orthodontics, Medical University of Graz
Graz, Styria, 8010, Austria
Location status: Recruiting
NCT Number: NCT07419269
The aim of this study is to determine whether jawbone augmentations using allogeneic and autogenous bone blocks lead to comparable three-dimensional clinical and radiological outcomes.
In addition, the study seeks to investigate whether there are differences regarding safety, biocompatibility, complications, and PROMs.
Furthermore, it aims to clarify whether differences exist between the two groups with respect to implant condition (one year after implantation and during annual follow-ups for up to five years).
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Graz, Styria, 8010, Austria
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Partially edentulous patients in need of implant therapy and presenting an insufficient bone volume (horizontal ridge width <5mm) to allow placing a standard diameter implant defect-free in a prosthetically ideal position will be included.
In the control group, the blocks will be adapted to the defect site morphology. With a small drill, holes for fixation will be prepared and the bone blocks will be immobilized with one or two screws. Subsequently, a layer of bone particles will be applied if needed to cover the autogenous bone and to fill up voids.
Partially edentulous patients in need of implant therapy and presenting an insufficient bone volume (horizontal ridge width <5mm) to allow placing a standard diameter implant defect-free in a prosthetically ideal position.
Based on CT/CBCT scans of the patient, the allogenic bone block has already been virtually designed using 3D CAD/CAM technology prior to surgery.
The individually milled bone graft Botiss maxgraft® bonebuilder (allogenic bone block), optional addition of MinerOss® A (allogenic bone granules) will then be covered with Argonaut® (porcine collagenbased membrane).
Time frame: at screening after augementation (= day 0) 180 days past augmentation (=implantation) 1 year after 2nd stage surgery 2 years after 2nd stage surgery 3 years after 2nd stage surgery 4 years after 2nd stage surgery 5 years after 2nd stage surgery
Contact information is provided by the study sponsor or research team.
Medical University of Graz
Other
Acronym: IndiALLO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718932
Alveolar Bone Loss, Bone Diseases
Thessaloniki, Greece
View Trial DetailsNCT07669792
Alveolar Bone Loss, Bone Diseases
Cairo, Egypt
View Trial DetailsNCT07433322
Alveolar Bone Loss, Bone Diseases
Richmond, Virginia, United States
View Trial DetailsNCT07638319
Alveolar Bone Grafting, Alveolar Bone Loss
Caparica, Monte Da Caparica, Portugal
View Trial Details